The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes
| Autor: | Shaun G, Goodman, Wei, Huang, Andrew T, Yan, Andrzej, Budaj, Brian M, Kennelly, Joel M, Gore, Keith A A, Fox, Robert J, Goldberg, Frederick A, Anderson, Ana, Vegas-Nunez |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Male
medicine.medical_specialty Acute coronary syndrome medicine.medical_treatment Angina Interquartile range Internal medicine Outcome Assessment Health Care medicine Humans Myocardial infarction Angina Unstable Registries Acute Coronary Syndrome Coronary Artery Bypass Practice Patterns Physicians' Cardiac catheterization Aged Quality of Health Care Unstable angina business.industry Data Collection Percutaneous coronary intervention Middle Aged medicine.disease Clopidogrel Treatment Outcome Research Design Cardiology Female Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | American heart journal. 158(2) |
| ISSN: | 1097-6744 |
| Popis: | Background The Global Registry of Acute Coronary Events (GRACE)—a prospective, multinational study of patients hospitalized with acute coronary syndromes (ACSs)—was designed to improve the quality of care for patients with an ACS. Expanded GRACE aims to test the feasibility of a simplified data collection tool and provision of quarterly feedback to index individual hospital management practices to an international reference cohort. Methods We describe the objectives; study design; study and data management; and the characteristics, management, and hospital outcomes of patients ≥18 years old enrolled with a presumptive diagnosis of ACS. Results From 2001 to 2007, 31,982 patients were enrolled at 184 hospitals in 25 countries; 30% were diagnosed with ST-segment elevation myocardial infarction, 31% with non–ST-segment myocardial infarction, 26% with unstable angina, and 12% with another cardiac/noncardiac final diagnosis. The median age was 65 (interquartile range 55-75) years; 24% were >75 years old, and 33% were women. In general, increases were observed over time across the spectrum of ACS (1) in the use in the first 24 hours and at discharge of aspirin, clopidogrel, β-blockers, and angiotensin-converting enzyme inhibitors/receptor blockers; (2) in the use at discharge of statins; (3) in the early use of glycoprotein IIb/IIIa inhibitors and low–molecular-weight heparin; and (4) in the use of cardiac catheterization and percutaneous coronary intervention. An increase in the use of primary percutaneous coronary intervention and a similar decrease in the use of fibrinolysis in ST-segment elevation myocardial infarction were also seen. Conclusions Over the course of 7 years, general increases in the use of evidence-based therapies for ACS patients were observed in the expanded GRACE. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect